BRAF and melanoma: ACA-28 and its lead derivative ACAGT-007a (GT-7; described as 2b in the previous reports) selectively induce apoptosis in several ERK-active melanoma cell lines, including SK-MEL-28, expressing the oncogenic mutant BRAF (V600E), by further stimulating ERK phosphorylation levels [7].